Article Information
History
- August 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rubeshan Perumal1,2,*,†,
- Neda Bionghi, MD*,3,
- Camus Nimmo4,
- Marothi Letsoalo1,
- Matthew J. Cummings5,
- Madeleine Hopson, MD3,
- Allison Wolf5,
- Shamim Al Jubaer6,
- Nesri Padayatchi1,
- Kogieleum Naidoo1,
- Michelle H. Larsen#,6 and
- Max O’Donnell#,1,5,7
- 1CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
- 2Division of Pulmonology and Critical Care, Department of Medicine, University of KwaZulu-Natal, Durban, South Africa
- 3Department of Medicine, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY, USA
- 4Francis Crick Institute, London, UK
- 5Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA
- 6Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA
- 7Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA
- ↵†Corresponding author; email: rubeshanperumal{at}gmail.com
Posted August 07, 2023.
Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: A systematic review and meta-analysis
